Cui Ma Selected Research

Hydroxyeicosatetraenoic Acids (HETE)

8/2021	[Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxic pulmonary arterial hypertension].
10/2018	Exosomal 15-LO2 mediates hypoxia-induced pulmonary artery hypertension in vivo and in vitro.
1/2018	15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma.
9/2015	15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertension.
9/2013	Placenta growth factor mediates angiogenesis in hypoxic pulmonary hypertension.
6/2013	15-lipoxygenase-1/15-hydroxyeicosatetraenoic acid promotes hepatocellular cancer cells growth through protein kinase B and heat shock protein 90 complex activation.
1/2013	Positive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertension.
10/2012	Platelet-derived growth factor (PDGF) induces pulmonary vascular remodeling through 15-LO/15-HETE pathway under hypoxic condition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cui Ma Research Topics

Disease

25	Hypoxia (Hypoxemia) 06/2022 - 11/2010
12	Pulmonary Hypertension 12/2020 - 10/2011
11	Neoplasms (Cancer) 06/2022 - 06/2013
9	Schizophrenia (Dementia Praecox) 01/2018 - 09/2009
9	Alzheimer Disease (Alzheimer's Disease) 06/2010 - 01/2004
8	Pulmonary Arterial Hypertension 08/2021 - 07/2012
7	Vascular Remodeling 05/2019 - 10/2011
3	Pre-Eclampsia (Preeclampsia) 12/2022 - 10/2020
3	Inflammation (Inflammations) 01/2022 - 09/2018
3	Hypertrophy 01/2019 - 10/2011
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018 - 01/2011
3	Major Depressive Disorder (Major Depressive Disorders) 08/2015 - 01/2008
2	Fibrosis (Cirrhosis) 08/2021 - 01/2020
2	Bone Resorption 01/2021 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2013
2	Dizziness (Lightheadedness) 01/2018 - 01/2008
2	Constipation 01/2018 - 01/2008
2	Shock 12/2016 - 10/2016
2	Mental Disorders (Mental Disorder) 10/2015 - 01/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2015 - 10/2014
2	Weight Gain 08/2011 - 01/2011
2	Pain (Aches) 09/2009 - 01/2008
1	Retinal Diseases 01/2022
1	Reperfusion Injury 01/2022
1	Infarction (Infarctions) 01/2022
1	Ischemia 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Retinal Neovascularization 01/2022
1	Myocardial Infarction 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Cardiotoxicity 01/2022
1	Rheumatoid Arthritis 12/2021
1	Hemorrhage 11/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2021
1	Osteoporosis 01/2021
1	Infections 01/2021
1	Carcinogenesis 01/2021

Drug/Important Bio-Agent (IBA)

11	AcidsIBA 08/2021 - 10/2011
9	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 08/2021 - 10/2011
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
8	Hydroxyeicosatetraenoic Acids (HETE)IBA 08/2021 - 10/2012
7	Biological ProductsIBA 01/2021 - 07/2011
6	Antipsychotic Agents (Antipsychotics)IBA 10/2015 - 09/2009
6	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 09/2013 - 11/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
5	Bromodeoxyuridine (BrdU)IBA 12/2020 - 10/2011
5	Clozapine (Clozaril)FDA LinkGeneric 10/2015 - 09/2009
4	Quetiapine Fumarate (Seroquel)FDA Link 01/2018 - 01/2008
4	Chlorpromazine (Thorazine)FDA Link 01/2018 - 09/2009
4	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2011 - 09/2009
3	EnzymesIBA 01/2022 - 01/2004
3	MicroRNAs (MicroRNA)IBA 06/2021 - 10/2018
3	Long Noncoding RNAIBA 01/2021 - 01/2019
3	Circular RNAIBA 01/2021 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 11/2012
3	MonocrotalineIBA 05/2019 - 01/2013
3	Small Interfering RNA (siRNA)IBA 01/2018 - 11/2012
2	Peptides (Polypeptides)IBA 06/2022 - 01/2004
2	UbiquitinIBA 01/2022 - 10/2018
2	Ferritins (Ferritin)IBA 01/2022 - 04/2019
2	Phosphotransferases (Kinase)IBA 10/2020 - 06/2013
2	Transcription Factors (Transcription Factor)IBA 04/2020 - 01/2018
2	erucylphosphocholineIBA 01/2020 - 01/2020
2	Caveolin 1IBA 01/2020 - 01/2020
2	AntioxidantsIBA 03/2019 - 01/2018
2	Environmental Pollutants (Pollutants, Environmental)IBA 12/2016 - 10/2016
2	Imatinib Mesylate (Gleevec)FDA Link 10/2016 - 10/2012
2	Neprilysin (Neutral Endopeptidase)IBA 10/2016 - 03/2005
2	Platelet-Derived Growth FactorIBA 10/2016 - 10/2012
2	BenzodiazepinesIBA 10/2015 - 07/2014
2	Sulpiride (neogama)IBA 08/2011 - 09/2009
2	Olanzapine (Zyprexa)FDA Link 08/2011 - 09/2009
2	Aripiprazole (Abilify)FDA Link 08/2011 - 09/2009
2	Apolipoproteins E (ApoE)IBA 06/2010 - 06/2005
2	ApolipoproteinsIBA 06/2010 - 06/2005
2	Aryldialkylphosphatase (Paraoxonase)IBA 04/2004 - 01/2004
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2022
1	HLA-G Antigens (HLA G)IBA 12/2022
1	LigandsIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	mouse MIRN29 microRNAIBA 01/2022
1	ponatinibIBA 01/2022
1	Axitinib (AG 013736)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	AutoantibodiesIBA 12/2021
1	Factor VII (Proconvertin)IBA 11/2021
1	AminopeptidasesIBA 08/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Bacteriocins (Lantibiotics)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 01/2021
1	CarcinogensIBA 01/2021

Therapy/Procedure

2	Resistance Training 01/2020 - 01/2020
2	Polypharmacy 10/2015 - 02/2015
1	Therapeutics 06/2022